SR
Sasidharan Rajesh
About Sasidharan Rajesh
Data last updated:
Sasidharan Rajesh is a Director at Sayre Therapeutics Private Limited (since 2021). The company operates in Healthcare. Sayre Therapeutics Private Limited reported revenue of ₹23.68 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sayre Therapeutics Private Limited U85110KA2015PTC079687 | Director | 23 Dec 2021 | 2015 | ₹23.68 Cr (FY 2025) | Active |
Board colleagues of Sasidharan Rajesh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mahendran Balachandran | 00121640 | Sayre Therapeutics Private Limited | Director |
| Shukrit Sudhir Chimote | 07082876 | Sayre Therapeutics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sasidharan Rajesh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sasidharan Rajesh
Sasidharan Rajesh currently holds 1 directorship: Sayre Therapeutics Private Limited (Director, since 23 Dec 2021, revenue ₹23.68 Cr (FY 2025)).
Sasidharan Rajesh was first appointed on 23 Dec 2021 as Director at Sayre Therapeutics Private Limited.
The current boards of Sasidharan Rajesh's companies include Mahendran Balachandran (Sayre Therapeutics Private Limited), Shukrit Sudhir Chimote (Sayre Therapeutics Private Limited).